These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Left main coronary artery disease in a 40-year-old man receiving HIV protease inhibitors. Hayes P; Muller D; Kuchar D Aust N Z J Med; 2000 Feb; 30(1):92-3. PubMed ID: 10800890 [No Abstract] [Full Text] [Related]
3. Vascular complications associated with use of HIV protease inhibitors. Gallet B; Pulik M; Genet P; Chedin P; Hiltgen M Lancet; 1998 Jun; 351(9120):1958-9. PubMed ID: 9654285 [No Abstract] [Full Text] [Related]
4. Lipid lowering therapy in patients with HIV infection. McBride M; Chin MT; Lee SM; Kelly B Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377 [No Abstract] [Full Text] [Related]
5. Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations. Cohen CJ AIDS Read; 2005 Oct; 15(10):528-32, 537-8. PubMed ID: 16265768 [TBL] [Abstract][Full Text] [Related]
7. Metabolic complications of protease inhibitors: what have we learned so far? Erbelding EJ Hopkins HIV Rep; 1999 Mar; 11(2):5, 15. PubMed ID: 11366249 [TBL] [Abstract][Full Text] [Related]
8. Changes in body shape and metabolic abnormalities. Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225 [TBL] [Abstract][Full Text] [Related]
9. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients. Chang ES; Tetreault DD; Liu YT; Beall GN J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549 [No Abstract] [Full Text] [Related]
10. Vascular complications associated with use of HIV protease inhibitors. Vittecoq D; Escaut L; Monsuez JJ Lancet; 1998 Jun; 351(9120):1959. PubMed ID: 9654286 [No Abstract] [Full Text] [Related]
11. Hyperlipidemia associated with the use of protease inhibitors. Smith JH; Martin GJ; Decker CF Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432 [No Abstract] [Full Text] [Related]
13. [Hyperlipidemia in patients with HIV infection treated with protease inhibitors]. López García F; Mora Rufete A; Escolano Hortelano CM; Gutiérrez Rodero F Rev Clin Esp; 1999 Nov; 199(11):780-1. PubMed ID: 10638253 [No Abstract] [Full Text] [Related]
14. A comparison of different protease inhibitors on coronary heart disease risk. Coleman CI; White CM Conn Med; 2007 Jan; 71(1):15-7. PubMed ID: 17288101 [No Abstract] [Full Text] [Related]
15. [Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors]. Dieleman JP; Hillebrand-Haverkort ME; van der Ende ME; Sturkenboom MC; Lange JM; Stricker BH Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2856-60. PubMed ID: 10065260 [TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
17. [Effects of high grade antiretroviral therapy on body fat distribution and metabolism]. Schwenk A Zentralbl Gynakol; 1999; 121(11):552-3. PubMed ID: 10612226 [No Abstract] [Full Text] [Related]
18. Trends in rates of myocardial infarction among patients with HIV. Holmberg SD; Moorman AC; Greenberg AE N Engl J Med; 2004 Feb; 350(7):730-2; author reply 730-2. PubMed ID: 14960752 [No Abstract] [Full Text] [Related]
19. Recent developments in HIV research. Boyle BA AIDS Read; 2002 Sep; 12(9):390-4, 407. PubMed ID: 12402802 [No Abstract] [Full Text] [Related]
20. HIV protease inhibitors and hyperlipidemia: a fatty acid connection. Spector AA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):7-9. PubMed ID: 16373621 [No Abstract] [Full Text] [Related] [Next] [New Search]